Mackenzie Financial’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,925	Closed	-$237K	–	1576
2023 Q2	$237K	Sell	4,925 -129	-3%	-$6.42K	﹤0.01%	1265
2023 Q1	$212K	Sell	5,054 -193	-4%	-$8.3K	﹤0.01%	1327
2022 Q4	$200K	Sell	5,247 -169	-3%	-$6.45K	﹤0.01%	1253
2022 Q3	$212K	Buy	+5,416	New	+$209K	﹤0.01%	1225
2022 Q2	–	Sell	-49,146	Closed	-$1.63M	–	1531
2022 Q1	$1.63M	Sell	49,146 -1,100	-2%	-$41.4K	﹤0.01%	790
2021 Q4	$2.14M	Buy	50,246 +1,300	+3%	+$54.4K	﹤0.01%	758
2021 Q3	$2.17M	Buy	48,946 +9,400	+24%	+$431K	﹤0.01%	740
2021 Q2	$2.25M	Buy	39,546 +16,400	+71%	+$1.16M	﹤0.01%	701
2021 Q1	$1.73M	Buy	+23,146	New	+$1.9M	﹤0.01%	711
2020 Q1	–	Sell	-8,573	Closed	-$619K	–	1164
2019 Q4	$619K	Buy	8,573 +8	+0.1%	+$984	﹤0.01%	822
2019 Q3	$1.2M	Buy	8,565 +71	+0.8%	+$11.9K	﹤0.01%	695
2019 Q2	$1.55M	Buy	8,494 +1,997	+31%	+$341K	﹤0.01%	679
2019 Q1	$1.03M	Buy	6,497 +3,734	+135%	+$541K	﹤0.01%	916
2018 Q4	$265K	Sell	2,763 -14,412	-84%	-$1.65M	﹤0.01%	1050
2018 Q3	$2.43M	Buy	17,175 +1,486	+9%	+$229K	0.01%	613
2018 Q2	$2.46M	Buy	15,689 +13,576	+642%	+$2.13M	0.01%	568
2018 Q1	$340K	Buy	+2,113	New	+$359K	﹤0.01%	793